Hayley Burgess, PharmD, MBA, BCPP, CPPS

HCA Healthcare

Disclosure(s): No financial relationships to disclose

Poster(s):

• 397 - Oral Vancomycin Versus Fidaxomicin for Clostridiodes difficile: A Comparative Retrospective Evaluation across a Large, Multi-center Healthcare System
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET